Breast cancer is the most common malignancy in women. Radiotherapy is frequently used
in patients with breast cancer, but some patients may be more susceptible to ionizing
radiation, and increased exposure to radiation sources may be associated to radiation
adverse events. This susceptibility may be related to deficiencies in DNA repair
mechanisms that are activated after cell-radiation, which causes DNA damage,
particularly DNA double strand breaks. Some of these genetic susceptibilities in
DNA-repair mechanisms are implicated in the etiology of hereditary breast/ovarian
cancer (pathologic mutations in the BRCA 1 and 2 genes), but other
less penetrant variants in genes involved in sporadic breast cancer have been
described. These same genetic susceptibilities may be involved in negative
radiotherapeutic outcomes. For these reasons, it is necessary to implement methods
for detecting patients who are susceptible to radiotherapy-related adverse events.
This review discusses mechanisms of DNA damage and repair, genes related to these
functions, and the diagnosis methods designed and under research for detection of
breast cancer patients with increased radiosensitivity.